Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.210
+0.140 (6.76%)
Aug 13, 2025, 4:00 PM - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $194.96 million as of August 13, 2025. Its market cap has increased by 12.11% in one year.
Market Cap
194.96M
Enterprise Value
136.86M
1-Year Change
12.11%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $194.96M, an increase of 55.70%. That is a compound annual growth rate of 3.66%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 573.91B |
| Johnson & Johnson | 414.67B |
| AbbVie | 349.28B |
| UnitedHealth Group | 236.02B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 225.74B |
| Novo Nordisk | 222.88B |